University of Montreal-led research has found that children who sustain concussion may need three months or longer to be ...

Fremanezumab is safe, effective, and tolerable for children and adolescents with episodic migraine, reducing monthly migraine ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine ...